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This study examined the effect of deltamethrin on some
of the neuropharmacological paradigms in a rat brain
such as the motor co-ordination test using a rotarod, the
pentobarbitone-induced sleeping time and pentylenetetrazole
(PTZ)-induced convulsion as well as the gamma aminobutyric
acid (GABA) level. Albino Wistar rats were used as the
experimental animals. Different neuropharmacological
paradigms such as the motor co-ordination by the rotarod,
pentobarbitone-induced sleeping time and the PTZ-
induced convulsion were examined after administering
deltamethrin orally at two doses, 150 mg/kg (LD 50) and
15 mg/kg (1/10 LD50). The GABA level in the rat brain
was estimated by HPLC after a single oral dose of 150 mg/
kg deltamethrin. Deltamethrin significantly reduced the
motor coordination, decreased the onset time and increased
the sleeping time duration induced by pentobarbitone. In
addition, it also decreased the onset time and increased
the duration of convulsions induced by PTZ at 150 mg/kg
(LD50) and 15 mg/kg (1/10 LD50), respectively. Further
deltamethrin administration decreased the GABA levels
in the cerebellum as well as in the whole brain (except the
cerebellum) significantly at the LD 50 dose level. There was
some correlation between the effect of deltamethrin on the
central GABA levels and its neuropharmacological effects.
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Introduction
Deltamethrin [(s)α-cyano-3phenoxy benzyl-(R)-cis-3-(2,2-
dibromovinyl)-2-2-dimethyl-cyclopropane carboxylate] is a
synthetic pyrethrroid with potent insecticidal properties.
Deltamethrin is used extensively not only as an ectoparasiticide
in animals but also in agricultural crop production and in
public health programs. The effects of deltamethrin on the
biochemical and histopathology of some organs after single
LD50 dose level in rats has been reported
 [12], and synthetic
pyrethroids such as cypermethrin act through the gamma
aminobutyric acid (GABA) gated chloride channels [8,11,15].
The neuropharmacological effect of pyrethroids such as
alfa-cypermethrin in rats has been described previously [13].
However, there are few reports on pharmacological effects
and modulation of brain GABA levels after deltamethrin
administration. This study examined the pharmacological
effects of deltamethrin with relation to its ability to modulate
the brain GABA levels.
Materials and Methods
Animals
Albino-Wistar rats of either gender, weighing 200 ± 10 g,
were used in this study. The animals were fasted overnight
with water being provided ad libitum. The experimental
protocol met the national guidelines for the care and use of
animals in laboratory research. The Institutional Animal
Ethics Committee approved the experimental protocol.
Dose of deltamethrin
Deltamethrin was administered orally at the LD 50 [12]
(150 mg/kg) and 1/10 LD50 (15 mg/kg).
Motor co-ordination by rotarod test
Dunham and Miya [3] suggested that skeletal muscle
relaxation induced by a test compound could be evaluated
by testing the ability of either mice or rats to remain on a
rotarod (Techno India, India). For this purpose, groups of
rats were trained to remain on a rotarod for 1 minute. The
animals were excluded and replaced if they failed to do so.
Thirty animals were considered and trained on the rotarod.
The rats were divided into three equal groups I, II and III
consisting of 10 animals each. Groups I and II received
deltamethrin orally at LD50 (150 mg/kg) and 1/10 LD50
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(15 mg/kg) dissolved in dimethylsulfoxide (DMSO; 1 ml),
respectively. Group III received only DMSO (1 ml) and was
used as the control. One hour after administering the
deltamethrin and DMSO, all the groups including the
control were placed on the rotarod, and the number of
animals falling from the rotarod during the scheduled time
were counted. The percentage was transformed into a probit
and compared with the control (Table 1).
Pentobarbitone-induced sleeping time: Thirty animals
were divided into three equal groups containing 10 animals
each. Pentobarbitone (Sigma, USA) was administered (40
mg/kg, ip) 1 h after administering 150 mg/kg and 15 mg/kg
deltamethrin to the animals in group I and II, respectively.
The sleeping time was recorded as the period starting with
the loss and regaining the righting reflex (Table 2). The
control group (group-III) received DMSO and pentobarbitone.
PTZ-induced convulsion
Thirty animals were divided into three equal groups
containing 10 animals each. Phenylenetetrazole (PTZ;
Sigma, USA) was administered (60 mg/kg i.p.) 1 h after
administering 150 mg/kg and 15 mg/kg deltamethrin
dissolved in DMSO to groups I and II, respectively. The
vehicle (DMSO) and PTZ were given to the control group-
III. The onset of the induction and duration of the tonic-
clonic convulsions were recorded (Table 3).
Determination of GABA level in brain
Twenty rats were divided into two equal groups consisting
of 10 animals each. Group I received deltamethrin at LD 50
(150 mg/kg) dissolved in DMSO (1 ml). In contrast, group
II received only DMSO (1 ml) and was used as the control.
Six hours after administering deltamethrin, the remaining
six (6) rats and control were euthanized The brain was
collected immediately and divided into two parts, the
cerebellum and the whole brain without the cerebellum.
Both portions were used to estimate the GABA level.
GABA is a major inhibitory neurotransmitter in the central
nervous system of all vertebrates, and is found in the
mammalian cerebellum, corpus striatum, cerebral cortex
and spinal cord. Its role in various neurological and mental
disorders has been reported.
Several methods for estimating the GABA levels in a
biological sample by high performance liquid chromatograph
(HPLC) have been published using fluorimetric [4] or
electrochemical detection [10] using pre-column derivatization
with O-phthalaldehyde (OPA). These methods are sensitive
but are generally unsuitable for automation. In addition, the
OPA derivatives are less stable than the OPA-tertiary-
butylthiol (TBT) derivatives. In this study, the level of
GABA was determined by HPLC-ECD by following its
derivatization with OPA and TBT using the method reported
by Allison et al., [1] which was modified by Manna et al
[13]. The following is the reaction for this process:
The derivative is a stable time-substituted isoindole.
Condition of HPLC
Separation was achieved on a Novapak RP-C 18 column
(3.9 × 150 mm). The mobile phase consisted of sodium
acetate (pH 5, 0.18 M, 55% v/v), and acetonitrile (45% v/v).
The flow rate was 1.5 ml/min, and the run time was 15 min.
A glassy carbon electrode set to 700 mV against a Ag-AgCl
reference electrode was used for electrochemical detection
(464-pulsed Electrochemical Detector; Waters, USA). The
temperature was 20
oC during analysis. The reagents were
Table 1. Effect of deltamethrin on the motor-coordination by
rotarod test in rats after a single oral dose of 150 (LD 50) and 15
mg/kg (1/10 LD50)
Group Probit  p-value
Vehicle treated
Deltamethrin treated
(150 mg/kg)
Deltamethrin treated
(15 mg/kg)
± 0.16
2.39 ± 0.60
5.40 ± 0.14
-
<0.01
<0.05
Table 2. Effect of deltamethrin on the pentobarbitone (40 mg/kg
i.p.) induced sleeping time in rats after a single oral dose of 150
(LD50) and 15 mg/kg (1/10 LD50)
Group Time of onset 
(min)
Duration
(min)
Pentobarbitone treated
Pentobarbitone + 
deltamethrin (150 mg/kg)
Pentobarbitone + 
deltamethrin (15 mg/kg)
5.75 ± 0.30 
3.40 ± 0.20**
4.70 ± 0.32*
67.10 ± 1.46
182.10 ± 2.38**
76.90 ± 3.50*
Note: Values are mean ± SE, n = 10 in each group; *:  p < 0.05, **: p <
0.01 as compared to control.
Table 3. Effect of deltamethrin on pentylenetetrazole (60 mg/kg
i.p.) induced convulsion in rats after a single oral dose of 150
(LD50) and 15 mg/kg (1/10 LD50)
Group Time of onset 
(min)
Duration
(min)
Pentylenetetrazole 
induced (control)
Pentylenetetrazole + 
deltamethrin  (150 mg/kg)
Pentylenetetrazole + 
deltamethrin (15 mg/kg)
4.65 ± 0.43
2.80 ± 0.20*
3.85 ± 0.44*
42.50 ± 2.82
123.70 ± 3.08**
50.90 ± 2.22**
Note: Values are mean ± SE, n = 10 in each group; *:  p < 0.05, **:
p < 0.01 as compared to control.Effect of deltamethrin on brain GABA levels 135
0.1 M HClO4, GABA stock (1.2, 0.625, 0.313 and 0.156
mM), 1.0 M carbonate buffer and a working reagent (0.0671
g of OPA dissolved in 50 ml methyl alcohol with 56 µl of
TBT added).
Sample preparation
In these experiments, the cerebellum and whole brain
without the cerebellum were weighted separately, homogenized
in 0.1 M HClO4 and the particulate matter was removed by
centrifugation and filtration. The clarified supernatant was
diluted with 0.1 M HClO4 to give a total dilution factor of
200 for the original brain samples.
Procedure
Twenty µl of the AVA (5-amino valeric acid) stock (internal
standard) and 40 µl of GABA stock was added to 500 µl of
the diluted brain homogenate and mixed thoroughly. Eight
hundred µl of the working reagent and 200 µl of the above
mixture were added to the sample and mixed thoroughly
(the flask was kept capped to contain the pungent thiol
odor). The mixture was allowed to react at room temperature
for 6 min and 50 µl of the derivatized sample was injected,
run for 15 min. The retention time (RT) of the derivatized
and as well as the unknown sample were found to be at
4.915 min and 5.137 min, respectively. The data was
recorded and the analysis was carried out using the Millennium
package (Waters, USA). The GABA concentration is expressed
as mg/g of wet tissue.
Statistical analysis
All the values are expressed as the mean ± SE. Statistical
analysis was carried out using SPSS 10.1 software (SPSS,
USA). The statistical significance of the differences between
the two means was assessed using one-way ANOVA. A
probability level at 5% or 1% (p < 0.05 or p<0.01) was
considered significant.
Results
Pharmacological test
Table 1 shows the percentage of animals present in the
rotarod were transformed into a probit following the single
oral dose of  deltamethrin at either 150 and 15 mg/kg.
Deltamethrin produced significant ataxia at both LD 50
(p < 0.01) and 1/10 LD50 ( p < 0.05). Table 2 shows that
deltamethrin significantly increased the duration of the
pentobarbitone induced sleeping time (p < 0.01) while it
decreased the onset time at both dose levels. Table 3 shows
that deltamethrin significantly increased the duration of the
tonic-clonic convulsions induced by PTZ (p < 0.01) at
150 mg/kg, and significantly decreased the onset time of the
convulsions (p< 0.05) at the LD50 dose and non significantly
at the 1/10 LD50 dose.
Brain GABA level
Table 4 shows the GABA concentrations in the cerebellum
and whole brain without the cerebellum in the brain of the
rats following a single dose of 150 mg/kg deltamethrin. The
table shows that the GABA concentration was significantly
lower (p < 0.01) in the cerebellum and the total brain
without the cerebellum.
Discussion
The restlessness, respiratory distress and violent convulsions
in rats administered deltamethrin suggest CNS stimulation.
After 3-5 hours of oral administration, the animals showed a
defined sequence of toxicity such as choreoathetosis, a loss
of the righting reflex followed by tonic-clonic convulsions.
The GABA receptor complex is an important target site for
type-II pyrethroids such as cypermethrin [14,2,7].
Deltamethrin potentiated the PTZ-induced convulsions in
rats. Some GABA antagonists do not interact with the
GABA binding site itself but interact with separate sites on
or near the chloride channel, such as non competitive
antagonists e.g. the PTZ block GABA mediated Cl
− flux,
and therefore act as a potent convulsant. The GABA level in
the brain was higher in the cerebellum portion than in the
remainder of the brain in the both control and experimental
rat. Deltamethrin decreased the GABA levels significantly
in both the cerebellum portion and in the remaining potion
of the whole brain. Cypermethrin, which is a type II
pyrethroid, also decreased the GABA level in the brain [13].
The decrease in the GABA level might be due either to the
decreased synthesis or increased catabolism of GABA
resulting in the inactivation of the Cl
− channel leading to
excitation and convulsion. Deltamethrin increased the
pentobarbitone induced sleeping time in rats.
On the other hand, pentobarbitone reduced the CNS
excitation symptoms caused by deltamethrin, which were
corroborated by the findings reported Forshaw et al. [5],
who showed that the voltage dependent chloride channel is a
toxicologically significant site of action for deltamethrin,
and that chloride channel agonists such as pentobarbitone
are effective therapy against type-II pyrethroid poisoning.
The deltamethrin-induced potentiation of the sleeping time
after pentobarbitone can be deduced because of the
inhibitory action on the hepatic drug metabolizing enzymes
Table 4. Concentration between the GABA in the brain of rats
after a single oral dose of 150 mg/kg deltamethrin
Organ Control
(ppm)
Experimental 
(ppm)
Cerebellum
Brain without cerebellum
1065 ± 88.00
0598 ± 32.21
168 ± 24.46**
158 ± 28.00**
Note: Values are mean ± SE (n = 6); ** p < 0.01 as compared to control.136 S. Manna et al.
by the pyrethroids type-II [9].
Pentobarbitone potentiates the GABA induced chloride
conductance and simultaneously depresses the voltage
activated Ca
++ currents at the lower concentration. However,
at higher concentrations, the chloride conductance was
increased in the absence of GABA [6]. One consequence of
the inhibition of these Ca
++ channels might be a blockade of
Ca
++ entry into the presynaptic nerve terminals, which
would inhibit the release of the excitatory neurotransmitters
such as glutamate, resulting in a net reduction of excitatory
synaptic transmission.
In conclusion, there was a correlation between the effects
of pyrethroid type-II (deltamethrin) on the brain GABA
level and its neuropharmacological effects.
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